GYRE NASDAQ
Gyre Therapeutics, Inc.
1W: -11.7%
1M: -20.1%
3M: -25.4%
YTD: -9.2%
1Y: -45.8%
3Y: +79.1%
5Y: -89.4%
$6.06
-0.12 (-1.94%)
Weekly Expected Move ±9.4%
$5
$6
$7
$7
$8
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$117M
Revenue
+16.3% YoY
$-6M
Net Income
-186.7% YoY
$3M
Free Cash Flow
+128.8% YoY
94.6%
Gross Margin
-41.5%
Op. Margin
-38.3%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-7.4%
ROA-4.3%
ROIC1.1%
Valuation
P/E-88.3
P/B5.5
EV/EBITDA229.4
Leverage
Debt/Equity0.01
Current Ratio5.60
Interest Cov.0.0x
Quality Scores
Piotroski F6/9
Altman Z16.76
Beneish M-2.57